Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 58.80
-0.20 (-0.34%)
Sep 8, 2026, 1:30 PM CST
Bionime Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,547 | 4,003 | 3,949 | 4,549 | 4,685 | 4,566 | |
Market Cap Growth | -4.94% | 1.37% | -13.19% | -2.90% | 2.61% | 12.53% |
Enterprise Value | 6,828 | 6,608 | 6,522 | 6,842 | 6,677 | 6,279 |
Last Close Price | 58.80 | 58.93 | 58.26 | 65.37 | 65.62 | 62.68 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 732.70 | 51.47 | 52.23 |
Forward PE | - | 59.41 | 59.41 | 57.48 | 51.04 | 70.09 |
PS Ratio | 2.65 | 2.18 | 2.04 | 2.59 | 2.12 | 2.47 |
PB Ratio | 2.15 | 2.28 | 2.09 | 2.28 | 2.25 | 2.20 |
P/TBV Ratio | 3.86 | 3.62 | 3.19 | 3.39 | 2.28 | 2.22 |
P/FCF Ratio | 191.61 | 11.82 | - | - | 1014.74 | 34.53 |
P/OCF Ratio | 36.11 | 8.09 | 202.21 | 22.36 | 32.93 | 16.93 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.98 | 3.59 | 3.37 | 3.90 | 3.02 | 3.39 |
EV/EBITDA Ratio | - | - | 10002.58 | 53.40 | 24.96 | 29.36 |
EV/EBIT Ratio | - | - | - | - | 50.81 | 83.40 |
EV/FCF Ratio | 287.75 | 19.51 | - | - | 1446.18 | 47.48 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.26 | 1.74 | 1.68 | 1.41 | 1.09 | 0.98 |
Debt / EBITDA Ratio | - | - | 289.51 | 20.41 | 8.29 | 9.27 |
Debt / FCF Ratio | 111.85 | 9.03 | - | - | 491.50 | 15.36 |
Net Debt / Equity Ratio | 1.08 | 1.47 | 1.47 | 1.19 | 0.96 | 0.83 |
Net Debt / EBITDA Ratio | -14.75 | -61.33 | 4269.93 | 18.48 | 7.44 | 8.03 |
Net Debt / FCF Ratio | 95.68 | 7.60 | -16.71 | -26.41 | 431.36 | 12.99 |
Asset Turnover | 0.30 | 0.32 | 0.35 | 0.34 | 0.46 | 0.41 |
Inventory Turnover | 2.22 | 2.36 | 2.19 | 2.02 | 2.14 | 1.92 |
Quick Ratio | 0.45 | 0.50 | 0.48 | 0.62 | 0.70 | 0.53 |
Current Ratio | 0.77 | 0.75 | 0.77 | 1.00 | 1.16 | 1.05 |
Return on Equity (ROE) | -14.16% | -9.84% | -6.49% | 0.32% | 4.42% | 4.31% |
Return on Assets (ROA) | -3.39% | -2.15% | -1.75% | -0.16% | 1.72% | 1.04% |
Return on Invested Capital (ROIC) | -7.06% | -4.38% | -3.44% | -0.32% | 3.34% | 2.02% |
Return on Capital Employed (ROCE) | -8.50% | -5.40% | -4.50% | -0.40% | 3.70% | 2.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -6.30% | -4.50% | -3.22% | 0.14% | 1.94% | 1.91% |
FCF Yield | 0.52% | 8.46% | -4.22% | -1.97% | 0.10% | 2.90% |
Dividend Yield | - | - | - | 2.78% | 2.91% | 2.90% |
Payout Ratio | - | - | - | 2056.45% | 133.16% | 142.18% |
Buyback Yield / Dilution | -6.14% | -0.18% | 0.44% | 0.28% | -0.98% | -0.75% |
Total Shareholder Return | -6.14% | -0.18% | 0.44% | 3.06% | 1.93% | 2.15% |